A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients
Clinical trial NCT00386139 · COMPLETED
Trial details
- NCT number
- NCT00386139
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2007-07-01
- Enrollment
- 881
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.